Skip to main content

Table 1 Demographic data and underlying disorder

From: Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study

Male (n) 24
Female (n) 8
Age (years) 59.3 + 13.2
Duration of catheterization (months) 28.80 + 48.02
Underlying disease (n)
 Multiple Sclerosis 10
 Spinal Cord lesion 15
 ischemic stroke 2
 central cord syndrome 1
 Critical illness polyneuropathy 1
 Guillan-Barré-Syndrome 1
 others 2